Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea.
Endocrinol Metab (Seoul). 2024 Oct;39(5):813-818. doi: 10.3803/EnM.2024.2014. Epub 2024 Aug 28.
Prior research has highlighted poor clinical outcomes in coronavirus disease 2019 (COVID-19)-infected patients with diabetes; however, susceptibility to COVID-19 infection in patients with diabetes has not been extensively studied. Participants aged ≥30 years who underwent COVID-19 testing from December 2019 to April 2020 were analyzed using the National Health Insurance Service data in South Korea. In a cohort comprising 29,433 1:1 propensity score-matched participants, COVID-19 positivity was significantly higher in participants with diabetes than in those without diabetes (512 [3.5%] vs. 395 [2.7%], P<0.001). Logistic regression analysis indicated that diabetes significantly increased the risk of COVID-19 test positivity (odds ratio, 1.307; 95% confidence interval, 1.144 to 1.493; P<0.001). Patients with diabetes exhibited heightened COVID-19 infection rates compared to individuals without diabetes, and diabetes increased the susceptibility to COVID-19, reinforcing the need for heightened preventive measures, particularly considering the poor clinical outcomes in this group.
先前的研究强调了 2019 冠状病毒病(COVID-19)感染患者中糖尿病患者的临床预后较差;然而,糖尿病患者对 COVID-19 感染的易感性尚未得到广泛研究。使用韩国国家健康保险服务的数据,对 2019 年 12 月至 2020 年 4 月期间接受 COVID-19 检测的年龄≥30 岁的参与者进行了分析。在包含 29433 名 1:1 倾向评分匹配参与者的队列中,糖尿病患者 COVID-19 阳性率显著高于非糖尿病患者(512 [3.5%] vs. 395 [2.7%],P<0.001)。逻辑回归分析表明,糖尿病显著增加了 COVID-19 检测阳性的风险(优势比,1.307;95%置信区间,1.144 至 1.493;P<0.001)。与非糖尿病患者相比,糖尿病患者 COVID-19 感染率较高,糖尿病增加了 COVID-19 的易感性,这强化了需要采取强化预防措施的必要性,特别是考虑到该人群的临床预后较差。